BMRN fund manager activity
BioMarin Pharmaceutical Inc · Nasdaq. Reported by 9 tracked fund managers in their 13F filings, Q1 2014 to Q2 2026.
Q4 2024
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Added | 14,746,235 | $969,270,027 | 0.56% | Feb 13, 2025 |
| Paul Singer - Elliott Investment Management | No change | 3,500,338 | $230,077,217 | 2.54% | Apr 28, 2025 |
| Ken Fisher - Fisher Asset Management | Added | 13,966 | $918,007 | 0.00% | Feb 5, 2025 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 11,734 | $771,276 | 0.01% | Feb 14, 2025 |
| Viking Global Investors | Added | 10,510,550 | $690,858,452 | 2.24% | Feb 14, 2025 |
Q3 2024
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Trimmed | 13,898,318 | $976,912,772 | 0.55% | Nov 13, 2024 |
| Paul Singer - Elliott Investment Management | No change | 3,500,338 | $246,038,758 | 2.36% | Nov 14, 2024 |
| Ken Fisher - Fisher Asset Management | Added | 13,546 | $952,148 | 0.00% | Nov 12, 2024 |
| Joel Greenblatt - Gotham Asset Management | New | 23,395 | $1,644,435 | 0.02% | Nov 14, 2024 |
| Torray Funds | Sold out | — | — | 0.00% | Nov 5, 2024 |
| Viking Global Investors | Added | 9,753,293 | $685,558,965 | 2.50% | Nov 14, 2024 |
Newer quarters · Older quarters